AlphaCentric Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,125,000	Closed	-$934K	–	254
2024 Q3	$934K	Hold	1,125,000	–	–	0.69%	51
2024 Q2	$976K	Hold	1,125,000	–	–	0.72%	46
2024 Q1	$1.7M	Hold	1,125,000	–	–	1.02%	31
2023 Q4	$973K	Hold	1,125,000	–	–	0.65%	56
2023 Q3	$1.51M	Buy	1,125,000 +315,000	+39%	+$422K	0.85%	38
2023 Q2	$1.45M	Buy	810,000 +570,000	+238%	+$1.02M	0.8%	44
2023 Q1	$934K	Buy	+240,000	New	+$934K	0.64%	57
2021 Q4	$900K	Buy	140,000 +4,000	+3%	+$25.7K	0.26%	37
2021 Q3	$792K	Buy	136,000 +54,500	+67%	+$317K	0.2%	43
2021 Q2	$841K	Buy	81,500 +29,500	+57%	+$304K	0.23%	33
2021 Q1	$547K	Buy	52,000 +35,000	+206%	+$368K	0.18%	41
2020 Q4	$263K	Buy	+17,000	New	+$263K	0.11%	48